• Atopia Therapeutics SA

    GE
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-660.1.581.016-8
    Sector: Research and development

    Age of the company

    8 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    100'000

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Atopia Therapeutics SA

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Atopia Therapeutics SA

    • Atopia Therapeutics SA is a Company limited by shares (AG) with its legal headquarters in Genève. Atopia Therapeutics SA belongs to the industry «Research and development» and is currently active.
    • The management consists of 3 persons. The company was founded on 03.06.2016.
    • The last commercial register change was made on 30.09.2024. All changes can be viewed under the section «Notifications» and saved as a PDF.
    • The Enterprise Identification Number of the company Atopia Therapeutics SA is the following: CHE-346.109.235.
    • Companies with the same address as Atopia Therapeutics SA: Association Genilem, Association Health Innovation and Investment Exchange, AVA Legal powered by Jaci Ohayon.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Le développement de molécules dans le domaine du traitement de l'asthme et autres maladies allergiques ou inflammatoires; détention, administration et gestion de participation dans des sociétés en Suisse et à l'étranger à l'exception des opérations prohibées par la LFAIE (cf. statuts pour but complet).

    Customise the company purpose with just a few clicks.

    Other company names

    Source: SOGC

    Past and translated company names

    • Atopia Therapeutics Ltd
    • Atopia Therapeutics AG
    • HpVac Ltd
    • HpVac AG
    • HpVac SA
    • GBC-HpVac SA
    • GBC-HpVac Ltd
    • GBC-HpVac AG
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Atopia Therapeutics SA

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 240930/2024 - 30.09.2024
    Categories: Change in capital

    Publication number: HR02-1006141708, Commercial Registry Office Geneva, (660)

    Atopia Therapeutics SA, à Genève, CHE-346.109.235 (FOSC du 17.06.2024, p. 0/1006059238). L'inscription no. 11515 du 12.06.2024 est rectifiée en ce sens que le capital-actions est de CHF 132'863, 05, entièrement libéré, divisé en 13'286'305 actions de CHF 0.01, nominatives, liées selon statuts.

    SOGC 240617/2024 - 17.06.2024
    Categories: Change of company name, Change in capital, Change in management

    Publication number: HR02-1006059238, Commercial Registry Office Geneva, (660)

    HpVac SA, à Genève, CHE-346.109.235 (FOSC du 31.05.2023, p. 0/1005757457).

    Nouvelle raison sociale:
    Atopia Therapeutics SA [Atopia Therapeutics AG] [Atopia Therapeutics Ltd]. Augmentation ordinaire du capital-actions porté de CHF 100'000, 01 à CHF 132'863, 04 par l'émission de 3'286'304 actions de CHF 0.01, nominatives, liées selon statuts, entièrement libérées par compensation de créances à hauteur de CHF 530'245 et en espèces pour le solde.

    Capital-actions:
    CHF 132'863, 04, entièrement libéré, divisé en 13'286'305 actions de CHF 0.01, nominatives, liées selon statuts. Statuts modifiés le 29.05.2024.

    Nouvel administrateur:
    Chevalier Grégoire, de France, à Paris, FRA, avec signature collective à deux.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm